Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-02-13 15:19 |
6K: Purple Biotech Convenes a Head & Neck Cancer Scientific Advisory Board in P…
|
English | 174.5 KB | ||
| 2024-02-13 15:19 |
6K: Purple Biotech Convenes a Head & Neck Cancer Scientific Advisory Board in P…
|
English | 36.7 KB | ||
| 2024-02-01 15:48 |
Purple Biotech Reaches Recommended Phase 2 Dose for NT219
|
English | 163.1 KB | ||
| 2024-02-01 15:48 |
Purple Biotech Reaches Recommended Phase 2 Dose for NT219
|
English | 36.6 KB | ||
| 2024-01-27 21:43 |
Receipt of Nasdaq Minimum Bid Price Notification-6K
|
English | 127.6 KB | ||
| 2024-01-27 21:43 |
Receipt of Nasdaq Minimum Bid Price Notification-6K
|
English | 36.6 KB | ||
| 2023-12-20 16:15 |
Appoints Dr. Yael Margolin to its Board of Directors
|
English | 170.0 KB | ||
| 2023-12-20 16:15 |
Appoints Dr. Yael Margolin to its Board of Directors
|
English | 36.6 KB | ||
| 2023-12-14 15:08 |
6K:Purple Biotech Completes Patient Enrollment in Phase 2 Pancreatic Cancer Tri…
|
English | 160.1 KB | ||
| 2023-12-14 15:08 |
6K:Purple Biotech Completes Patient Enrollment in Phase 2 Pancreatic Cancer Tri…
|
English | 36.7 KB | ||
| 2023-11-22 00:22 |
6K-Corporate Presentation November 2023
|
English | 5.8 MB | ||
| 2023-11-22 00:22 |
6K-Corporate Presentation November 2023
|
English | 36.6 KB | ||
| 2023-11-21 15:11 |
Reports Third Quarter 2023 Financial Results
|
English | 208.7 KB | ||
| 2023-11-21 15:11 |
Reports Third Quarter 2023 Financial Results
|
English | 36.8 KB | ||
| 2023-11-15 01:15 |
PROSPECTUS
|
English | 816.4 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
